Paper42576754
[Oral mucosal administration].
Liu T and 2 others. Hua Xi Kou Qiang Yi Xue Za Zhi, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Oral mucosal administration]. Papers, record 42576754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42576754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Mouth Mucosa | Major topic |
| Humans | |
| Administration, Oral | |
| Hydrogels | |
| Nanoparticles |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33984453 | Relevance of production method on the physical stability and in vitro biopharmaceutical performances of olanzapine orodispersible film. | Int J Pharm | 2021 | https://conductscience.org/library/papers/33984453 | PubMed |
| 2 | 29943281 | Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems. | AAPS PharmSciTech | 2018 | https://conductscience.org/library/papers/29943281 | PubMed |
| 3 | 18182449 | Clinical review: The role of advanced glycation end products in progression and complications of diabetes. | J Clin Endocrinol Metab | 2008 | https://conductscience.org/library/papers/18182449 | PubMed |
| 4 | 41253034 | A dynamic wet-adhesive hydrogel loaded with ROS-responsive liposomes for chemotherapy-induced oral mucositis treatment. | Colloids Surf B Biointerfaces | 2026 | https://conductscience.org/library/papers/41253034 | PubMed |
| 5 | 39976299 | Transmucosal drug delivery: prospects, challenges, advances, and future directions. | Expert Opin Drug Deliv | 2025 | https://conductscience.org/library/papers/39976299 | PubMed |
| 6 | 31899168 | Sublingual microvasculature in diabetic patients. | Microvasc Res | 2020 | https://conductscience.org/library/papers/31899168 | PubMed |
| 7 | 36351519 | Buccal films: A review of therapeutic opportunities, formulations & relevant evaluation approaches. | J Control Release | 2022 | https://conductscience.org/library/papers/36351519 | PubMed |
| 8 | 27454043 | Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. | Nat Mater | 2016 | https://conductscience.org/library/papers/27454043 | PubMed |
| 9 | 32279775 | Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives. | Mater Sci Eng C Mater Biol Appl | 2020 | https://conductscience.org/library/papers/32279775 | PubMed |
| 10 | 28888014 | Development and evaluation of thymol-chitosan hydrogels with antimicrobial-antioxidant activity for oral local delivery. | Mater Sci Eng C Mater Biol Appl | 2017 | https://conductscience.org/library/papers/28888014 | PubMed |
| 11 | 40461915 | Recent Advances in Development of Buccal Formulations: From Small to Macromolecules. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/40461915 | PubMed |
| 12 | 23035030 | Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems. | PDA J Pharm Sci Technol | 2012 | https://conductscience.org/library/papers/23035030 | PubMed |
| 13 | 33523951 | A microneedle platform for buccal macromolecule delivery. | Sci Adv | 2021 | https://conductscience.org/library/papers/33523951 | PubMed |
| 14 | 28203065 | Oral drug therapy in elderly with dysphagia: between a rock and a hard place! | Clin Interv Aging | 2017 | https://conductscience.org/library/papers/28203065 | PubMed |
| 15 | 32750605 | Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells. | Colloids Surf B Biointerfaces | 2020 | https://conductscience.org/library/papers/32750605 | PubMed |
| 16 | 34702445 | Bacterial cellulose adhesive composites for oral cavity applications. | Carbohydr Polym | 2021 | https://conductscience.org/library/papers/34702445 | PubMed |
| 17 | 27899918 | Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27899918 | PubMed |
| 18 | 29687750 | Non-invasive systemic drug delivery through mucosal routes. | Artif Cells Nanomed Biotechnol | 2018 | https://conductscience.org/library/papers/29687750 | PubMed |
| 19 | 27358561 | Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/27358561 | PubMed |
| 20 | 37160247 | Long-acting parenteral drug delivery systems for the treatment of chronic diseases. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/37160247 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42576754
GET https://conductscience.org/api/papers/v1/42576754/references?page=2